Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use COSOPT PF safely and effectively. See full prescribing information for COSOPT PF.COSOPT® PF (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5% Initial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
COSOPT® PF is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target IOP determined after multiple measurements over time). The IOP-lowering of COSOPT® administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day [see Clinical Studies (14.1)].
- generic_name
- dorzolamide hydrochloride and timolol maleate
- product_names
- Dorzolamide Hydrochloride and Timolol Maleate
- ndc
- 17478-604, 17478-604-01, 17478-604-90, 17478-604-30, 17478-604-00, 17478-604-15
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en